Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Iterum Therapeutics Plc
Swot
Iterum Therapeutics Plc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Iterum Therapeutics Plc has 17 Strengths, 5 Weaknesses, 0 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(17)
Weakness
(5)
Opportunity
(0)
Threats
(1)
Others
(1)
Rising Momentum: Momentum Score Weekly Gainers
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Stocks whose current price is 20% higher than week low, and more than previous close
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Annual Net Profits improving for last 2 years
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
RSI indicating price strength
Volume Shockers
High Volume, High Gain
Stocks with Quarter Change % less than Industry
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Stocks Underperforming their Industry Price Change in the Quarter
MFs decreased their shareholding last quarter
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
